ArticleCommunications medicine2021
A spatial and dynamic solution for allocation of COVID-19 vaccines when supply is limited.
Article in Communications medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- Impact of perceived severity on depression, anxiety, and insomnia among Chinese community residents during the COVID-19 lockdown.World journal of psychiatry · 2025Article
- Emergence of shield immunity during spatial contagions.Npj complexity · 2025Article
- How enlightened self-interest guided global vaccine sharing benefits all: A modeling study.Journal of global health · 2023Article
- Predicting onset risk of COVID-19 symptom to support healthy travel route planning in the new normal of long-term coexistence with SARS-CoV-2.Environment and planning. B, urban analytics and city science · 2023Article
- A Spatiotemporal Solution to Control COVID-19 Transmission at the Community Scale for Returning to Normalcy: COVID-19 Symptom Onset Risk Spatiotemporal Analysis.JMIR public health and surveillance · 2023Article
- How to control the spatiotemporal spread of Omicron in the region with low vaccination rates.Frontiers in public health · 2022Article
- Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127.Frontiers in public health · 2022Article
- Tracking and Controlling the Spatiotemporal Spread of SARS-CoV-2 Lineage B.1.1.7 in COVID-19 Reopenings.GeoHealth · 2021Article
- Tracking and controlling the spatiotemporal spread of SARS-CoV-2 Omicron variant in South Africa.Travel medicine and infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Since most of the global population needs to be vaccinated to reduce COVID-19 transmission and mortality, a shortage of COVID-19 vaccine supply is inevitable. We propose a spatial and dynamic vaccine allocation solution to assist in the allocation of limited vaccines to people who need them most. Methods: We developed a weighted kernel density estimation (WKDE) model to predict daily COVID-19 symptom onset risk in 291 Tertiary Planning Units in Hong Kong from 18 January 2020 to 22 December 2020. Data of 5,409 COVID-19 onset cases were used. We then obtained spatial distributions of accumulated onset risk under three epidemic scenarios, and computed the vaccine demands to form the vaccine allocation plan. We also compared the vaccine demand under different real-time effective reproductive number (R Results: The estimated vaccine usages in three epidemiologic scenarios are 30.86% - 45.78% of the Hong Kong population, which is within the total vaccine availability limit. In the sporadic cases or clusters of onset cases scenario, when 6.26% of the total population with travel history to high-risk areas can be vaccinated, the COVID-19 transmission between higher- and lower-risk areas can be reduced. Furthermore, if the current R Conclusions: The proposed solution can be used to dynamically allocate limited vaccines in different epidemic scenarios, thereby enabling more effective protection. The increased vaccine usages associated with increased R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.